LICENSE AGREEMENT
(clinical usage of nanofat transfer method - patent pending)
This License Agreement ("Agreement") is entered into by and between
Licensor:
Dr. Galya Dragieva
Dr. Dragieva Aesthetics
Dufourstrasse 43
8008 Zurich, Switzerland
and
Licensee:
The signatory of this Agreement (name, address, contact information as provided on the separate online-registration form on the website https://www.drdragieva.ch/, "Licensee"), a licensed physician.
1. Preamble
The Licensor is the owner of European Patent Application no. 26176025.0 "Aesthetic procedure for skin rejuvenation, particularly for facial rejuvenation" (the "Patent Application"), filed on 26 April 2026 (claiming Priority of, inter alia, Swiss Patent Application no.000472/2025, filed on 30 April 2025), and related know-how ("Know-how").
The Licensee is interested in a clinical application of this nanofat transfer method ("Method") currently protected under a pending European Patent Application and related Know-how.
This Agreement grants the Licensee a non-exclusive, non-transferable right to use the Method protected under the current Patent Application and related Know-how.
2. Scope and Territory
2.1. The license is non-exclusive, non-transferable, and limited to the Licensees’ own medical practice.
2.2. The Method may only be applied by the Licensee personally. Teaching, sublicensing, or demonstration to third parties requires prior written permission from the Licensor.
2.3. Publication, reproduction, or disclosure of the Method in any scientific or commercial setting without prior written consent of the Licensor is prohibited.
3. Patent Application/ IP Status
The Method is currently protected under a pending European Patent Application. Further follow-up applications in other countries may follow.
4. License Term & Fee
4.1. This Agreement becomes effective upon payment of the licence fee (lump sum payment) through/on the website https://www.drdragieva.ch/ and is valid for a period of three (3) years.
4.2. The license fee is EUR 2’000.-. No additional fees will be charged during the term of the license.
4.3. After the three-year-period, a new license may be required depending on future IP status.
4.4. Early licensees, i.e. licensees who enter into this Agreement even before the Patent Application is granted, will not be subject to retroactive fees.
5. Confidentiality and Restrictions
The Licensee undertakes to maintain secrecy on all contractual Know-how for an indefinite period, that is, as long as the Know-how has not become general knowledge.
6. Disclaimer and Professional Responsibility
6.1. The Licensee is responsible for ensuring compliance with local medical regulations when applying the Method.
6.2. No guarantee is provided for patient outcomes. The Method must be applied within the scope of Licensee’s legal and professional responsibilities.
7. Publication and Scientific Use
7.1. Any publication, case report, or conference presentation based on the Method requires prior written approval from the Licensor.
7.2. Unauthorized disclosure may constitute a breach of intellectual property rights and lead to legal consequences.
8. Governing Law
8.1. This Agreement is governed by the laws of Switzerland.
8.2. All disputes shall be submitted to the exclusive jurisdiction of the competent courts in Zurich.
9. Severability
If any clause of this Agreement is deemed invalid, the remaining clauses shall remain in force. The invalid clause shall be replaced by one that comes closest in intent.
10. Acceptance
By providing all necessary contact information on the online-registration form including paying the licence fee, the Licensee confirms to be a licensed physician and agrees to the terms of this License Agreement.
LICENSE AGREEMENT
(clinical usage of nanofat transfer method - patent pending)
This License Agreement ("Agreement") is entered into by and between
Licensor:
Dr. Galya Dragieva
Dr. Dragieva Aesthetics
Dufourstrasse 43
8008 Zurich, Switzerland
and
Licensee:
The signatory of this Agreement (name, address, contact information as provided on the separate online-registration form on the website https://www.drdragieva.ch/, "Licensee"), a licensed physician.
1. Preamble
The Licensor is the owner of European Patent Application no. 26176025.0 "Aesthetic procedure for skin rejuvenation, particularly for facial rejuvenation" (the "Patent Application"), filed on 26 April 2026 (claiming Priority of, inter alia, Swiss Patent Application no.000472/2025, filed on 30 April 2025), and related know-how ("Know-how").
The Licensee is interested in a clinical application of this nanofat transfer method ("Method") currently protected under a pending European Patent Application and related Know-how.
This Agreement grants the Licensee a non-exclusive, non-transferable right to use the Method protected under the current Patent Application and related Know-how.
2. Scope and Territory
2.1. The license is non-exclusive, non-transferable, and limited to the Licensees’ own medical practice.
2.2. The Method may only be applied by the Licensee personally. Teaching, sublicensing, or demonstration to third parties requires prior written permission from the Licensor.
2.3. Publication, reproduction, or disclosure of the Method in any scientific or commercial setting without prior written consent of the Licensor is prohibited.
3. Patent Application/ IP Status
The Method is currently protected under a pending European Patent Application. Further follow-up applications in other countries may follow.
4. License Term & Fee
4.1. This Agreement becomes effective upon payment of the licence fee (lump sum payment) through/on the website https://www.drdragieva.ch/ and is valid for a period of three (3) years.
4.2. The license fee is EUR 2’000.-. No additional fees will be charged during the term of the license.
4.3. After the three-year-period, a new license may be required depending on future IP status.
4.4. Early licensees, i.e. licensees who enter into this Agreement even before the Patent Application is granted, will not be subject to retroactive fees.
5. Confidentiality and Restrictions
The Licensee undertakes to maintain secrecy on all contractual Know-how for an indefinite period, that is, as long as the Know-how has not become general knowledge.
6. Disclaimer and Professional Responsibility
6.1. The Licensee is responsible for ensuring compliance with local medical regulations when applying the Method.
6.2. No guarantee is provided for patient outcomes. The Method must be applied within the scope of Licensee’s legal and professional responsibilities.
7. Publication and Scientific Use
7.1. Any publication, case report, or conference presentation based on the Method requires prior written approval from the Licensor.
7.2. Unauthorized disclosure may constitute a breach of intellectual property rights and lead to legal consequences.
8. Governing Law
8.1. This Agreement is governed by the laws of Switzerland.
8.2. All disputes shall be submitted to the exclusive jurisdiction of the competent courts in Zurich.
9. Severability
If any clause of this Agreement is deemed invalid, the remaining clauses shall remain in force. The invalid clause shall be replaced by one that comes closest in intent.
10. Acceptance
By providing all necessary contact information on the online-registration form including paying the licence fee, the Licensee confirms to be a licensed physician and agrees to the terms of this License Agreement.